The present invention relates generally to apparatus and methods for sealing punctures in a body, and more particularly, to apparatus and methods for sealing a vascular puncture extending through tissue into a blood vessel, and to apparatus and methods for delivering a plug, sealant, and/or other material into a percutaneous puncture extending from a patient's skin to a blood vessel or other body lumen, e.g., to seal the puncture.
Apparatus and methods are known for accessing a patient's vasculature percutaneously, e.g., to perform a procedure within the vasculature, and for sealing the puncture that results after completing the procedure. For example, a hollow needle may be inserted through a patient's skin and overlying tissue into a blood vessel. A guide wire may be passed through the needle lumen into the blood vessel, whereupon the needle may be removed. An introducer sheath may then be advanced over the guide wire into the vessel, e.g., in conjunction with or subsequent to one or more dilators.
A catheter or other device may be advanced through the introducer sheath and over the guide wire into a position for performing a medical procedure. Thus, the introducer sheath may facilitate accessing and/or introducing various devices into the vessel, while minimizing trauma to the vessel wall and/or minimizing blood loss. Upon completing the procedure, the device(s) and introducer sheath may be removed, leaving a puncture extending between the skin and the vessel wall.
To seal the puncture, external pressure may be applied to the overlying tissue, e.g., manually and/or using sandbags, until hemostasis occurs. This procedure, however, may be time consuming and expensive, requiring as much as an hour of a medical professional's time. It is also uncomfortable for the patient, and may require the patient to remain immobilized in the operating room, catheter lab, or holding area. In addition, a risk of hematoma exists from bleeding before hemostasis occurs.
The present invention is directed to apparatus and methods for sealing a puncture in a body, and, more particularly, to apparatus and methods for providing temporary or permanent hemostasis within a vascular puncture extending into a blood vessel, and/or to apparatus and methods for delivering a sealant and/or other material into a percutaneous puncture extending from a patient's skin to a blood vessel or other body lumen.
In accordance with one embodiment, a system is provided for sealing a puncture extending through tissue that includes an introducer sheath and an elongate positioning or occlusion member. The introducer sheath includes a lumen and a distal end sized for insertion through a puncture. The elongate positioning member is sized for insertion into the introducer sheath lumen and includes an expandable element on a distal end of the positioning member and a tension indicator on a proximal end of the positioning member. Optionally, the system may include a sealant cartridge including a tubular member, a sealant disposed within the tubular member and a pusher member disposed within the tubular member for deploying the sealant distally from the tubular member when the tubular member is retracted proximally relative to the pusher member.
The tension indicator on the proximal end of the positioning member includes a proximal housing portion, a distal housing portion and a spring coupled to the proximal housing portion and the distal housing portion. The spring biases the proximal and distal housing portions together in a first position yet allows the proximal and distal housing portions to separate to a second extended position, e.g., where the spring is compressed or otherwise directed to a higher potential energy state. For example, a force sufficient to overcome the spring's bias may be less than a desired tension force applied to the positioning member during use, e.g., when the positioning member is pulled to cause the expandable element in an expanded position to contact a wall of a vessel sufficiently to seal the vessel from the puncture and/or avoid tenting of the wall of the vessel.
In one embodiment, the spring of the tension indicator may extend between a spring retaining ring and a shoulder portion of the proximal housing portion. Further, the spring may be disposed around a hollow cylinder and the hollow cylinder may be coupled to the distal housing portion. The hollow cylinder may be disposed around an internal cylindrical element and the internal cylindrical element and the hollow cylinder may be coupled to the spring retaining ring.
In accordance with another embodiment, an apparatus is provided for providing temporary hemostasis within a puncture extending through tissue to a body lumen. The tension indicator apparatus includes an elongate member with a proximal end, a distal end sized for introduction into a puncture through tissue, an expandable element on the distal end, and a tension indicator on the proximal end. In a collapsed condition, the expandable element is sized for introduction through the puncture into the body lumen and, in an expanded condition, the expandable element is larger than the puncture such that the expandable element may be pulled against a wall of the body lumen adjacent the puncture. The tension indicator is configured to indicate when sufficient is applied to the wall when the elongate member is pulled.
In one embodiment, the tension indicator includes a proximal housing portion configured to be held by a user, and a distal housing portion, the proximal and distal housing portions being movable away from one another, yet biased to move towards or against one another. For example, a spring, e.g., a compression or extension spring, may be disposed within the proximal housing portion for biasing the proximal housing portion towards the distal housing portion. When the spring bias is overcome, the proximal housing portion may move proximally away from the distal housing portion, thereby creating a space between the proximal and distal housing portions. The space may serve as a visual cue that the optimum amount of tension is being applied by the elongate member. The spring may have a spring constant selected such that a tension force sufficient to overcome the bias of the spring and cause the proximal housing portion to separate from the distal housing portion may correspond to the optimum amount of tension to be applied to provide temporary hemostasis without tenting the vessel wall or pulling the temporary hemostasis element out of the puncture tract during use. Thus, the spring constant may be selected to apply sufficient force against the wall of the body lumen by expandable element to substantially seal the body lumen from the puncture.
In accordance with still another embodiment, a method is provided for sealing a puncture extending through tissue to a body lumen. The method includes introducing an elongate member into the puncture until an expandable element thereon is disposed within the body lumen, expanding the expandable element within the body lumen, and retracting the elongate member until the expanded expandable element contacts a wall of the body lumen adjacent the puncture and a tension indicator on the elongate member indicates that sufficient tension is applied to the wall of the body lumen by the expandable element to substantially seal the puncture. Retracting the elongate member may include separating a proximal housing portion of the tension indicator from a distal housing portion of the tension indicator when the desired amount of tension is applied. In one embodiment, the tension indicator includes a spring and separating the proximal housing portion from the distal housing portion may include compressing the spring.
Optionally, the method may include one or more additional steps. For example, an introducer sheath may be introduced into the puncture before introducing the elongate member, and the elongate member may be introduced into the puncture through the introducer sheath. In addition or alternatively, a tubular member or other cartridge carrying a sealant therein may be advanced along the elongate member and into the puncture, and then retracted to expose the sealant within the puncture. After use, the expandable element may be collapsed, and the elongate member removed from the puncture, e.g., through any sealant delivered into the puncture.
Other aspects and features of the present invention will become apparent from consideration of the following description taken in conjunction with the accompanying drawings.
Turning to the drawings,
As best seen in
The introducer sheath 20 may be formed using known materials and/or methods, e.g., plastic with the tubular body and hub 23 substantially permanently connected together, e.g., using an interference fit, one or more mating connectors (not shown), bonding with adhesive, sonic welding, and the like. The hub 23 generally includes one or more seals (not shown) adjacent an opening 27, which may prevent flow of blood or other fluids out of the hub 23 from the lumen 26, yet accommodate insertion of one or more instruments into the lumen 26, such as the cartridge 120. Optionally, as shown, the hub 23 may include a side port 29 communicating with the lumen 26, e.g., for coupling a source of saline or other fluid (not shown) to the hub 23.
With additional reference to
A sealant 2 is provided in the distal portion of the cartridge 120 and a pusher member 130 is provided proximal to the sealant 2 within the cartridge 120. The sealant 2 may include a biocompatible, bioabsorbable, and/or expandable material, such as a freeze-dried hydrogel. The sealant 2 may have a solid or hollow cylindrical shape, a rolled sheet shape, a disk shape, or other shapes or cross-sections, such as elliptical, triangular, square, conical, disk, or polygonal shapes. For example, the sealant 2 may be formed from a solid material including a lumen 4 extending between proximal and distal ends thereof, as shown in
The sealant 2 may be substantially homogeneous or may include one or more different materials at one or more locations. For example, in one embodiment, the sealant 2 may include a carrier or core having first and second hydrogel precursors disposed thereon in an unreactive state, which may provide an adherent coating when the sealant 2 is exposed to an aqueous environment. In one embodiment, the sealant 2 may be formed from a biocompatible and/or bioabsorbable hydrogel, e.g., polyethylene glycol (“PEG”), or other synthetic material. For example, the hydrogel may include a lyophilized (i.e., freeze-dried) PEG polymer that includes hydrolytically degradable chemical groups, e.g., including a macroporous polymer network, which may uptake fluid and expand when exposed to an aqueous environment. The magnitude of expansion or swelling (pre to post hydration) may be significant, e.g., between about two and ten times (2×-10×) its lyophilized size based on volume.
In addition or alternatively, the sealant 2 may include pro-thrombotic material, e.g., including one or more biological pro-thrombotics, such as collagen, fibrin, carboxymethylcellulose, oxidized cellulose, alginates, gelatin, or other protein-based material, and/or synthetic materials, such as polyglycolic acids (PGA's), polyactides (PLA's), polyvinyl alcohol, and the like. Optionally, the sealant 2 may include one or more therapeutic and/or pharmaceutical agents, e.g., to promote healing, prevent infection, and/or other adverse medical events, and the like. Such agents may be embedded in the sealant material and/or applied as one or more coatings or layers. Exemplary materials and methods for making and using them are disclosed in U.S. Pat. Nos. 6,152,943, 6,165,201, 6,179,862, 6,514,534, 6,379,373, 6,703,047, 7,009,034, 6,887,974, and in co-pending U.S. patent application Ser. No. 10/454,362, filed Jun. 4, 2003, published as US 2004/0249342, Ser. No. 10/982,387, filed Nov. 5, 2004, published as US 2006/0034930, Ser. No. 10/982,384, filed Nov. 5, 2004, published as US 2006/0099238, and Ser. No. 11/465,791, filed Aug. 18, 2006 published as US 2007/0231366. The disclosures of these references are expressly incorporated by reference herein.
The sealant 2 may be disposed within the lumen 126 of the cartridge 120 proximate to the distal end 124, e.g., immediately adjacent the distal tip 125. Thus, when advanced into the introducer sheath 20 or otherwise within the puncture 90, the sealant 2 may remain out of direct or indirect contact with blood or other bodily fluids along the blood path. Optionally, the cartridge 120 may include a split distal end (not shown), e.g., formed by creating one or more relatively short longitudinal cuts or slots extending proximally from the distal end 124. The split distal end may facilitate retraction of the cartridge 120 relative to the sealant 2, e.g., by providing extra flexibility at the distal end 124, which may allow the distal end 124 to separate more easily from the sealant 2, e.g., as the sealant begins to expand upon being exposed to an aqueous environment, such as blood or other bodily fluids. The lumen 126 may be sized such that the cartridge 120 and sealant 2 are slidable relative to one another, e.g., to allow the cartridge 120 to be refracted proximally relative to the sealant 2 and/or pusher member 130.
With further reference to
The pusher member 130 may be substantially rigid, semi-rigid, and/or substantially flexible, having sufficient column strength to allow proximal movement of the cartridge 120 relative to the sealant 2 without buckling the pusher member 130 and/or to allow the distal tip 135 of the pusher member 130 to be “tamped” down on sealant 2 within a puncture, e.g., by pushing from the proximal end 132, as described elsewhere herein. The lumen 136 of the pusher member 130 may be sized to accommodate the positioning member 140, a guidewire (not shown), a flowable sealing compound, and/or fluid therethrough.
With continued reference to
For example, as shown in
Alternatively, the positioning element may be biased to an enlarged condition, but may be compressed to a contracted condition, e.g., by an overlying sleeve or other constraint (not shown). The constraint may be removed to expose the positioning element, allowing the expandable element to automatically expand to the enlarged condition. Additional information on expandable structures that may be provided on the positioning member 140 may be found in U.S. Pat. Nos. 6,238,412, 6,635,068, and 6,890,343. The entire disclosures of these references are expressly incorporated herein by reference.
Turning to
Optionally, the positioning member 140 and/or pusher member 130 may include one or more elements that engage when the cartridge 120 reaches a predetermined location when advanced distally along the positioning member 140, e.g., to limit subsequent proximal movement of the pusher member 130 relative to the positioning member 140. For example, as shown in
As an alternative to the latch element(s) 137, the pusher member 130 may simply include a relatively narrow region on the proximal end 132. Further alternatively, the latch element(s) 137 may be replaced by a separate collar or sleeve, one or more inwardly oriented detents, and the like (not shown) attached to or otherwise formed on the proximal end 132 of the pusher member 130. As an alternative to the raised element 145, the positioning member 140 may include a reduced diameter region (not shown) formed by providing a larger tube around a smaller inner tube or by machining, etching, or otherwise removing a portion of the tubular body of the positioning member 140 distal to the reduced region and the pusher member 130 may include a corresponding element (also not shown) that may allow distal advancement but prevent proximal retraction once the pusher member 130 is advanced a predetermined distance. Exemplary embodiments of cooperating elements are disclosed in co-pending U.S. patent application Ser. No. 10/982,384, filed Nov. 5, 2004, published as US 2006/0099238 and [Ser. No. 11/864,835, filed Sep. 28, 2007. The entire disclosures of these references are expressly incorporated by reference herein.
The reduced region (not shown) or raised element 145 may be provided at a predetermined location on the positioning member 140, e.g., a predetermined distance from the positioning element 146 that corresponds to a length of the pusher member 130. As the cartridge 120 (and consequently the pusher member 130) is advanced over the positioning member 140, e.g., until the sealant 2 is disposed adjacent the positioning element 146, the latch element 137 may pass freely over the raised element 145. Thereafter, the latch element 137 may prevent the pusher member 130 from being retracted again past the raised element 145 due to the blunt edge of the latch element 137 abutting the raised element 145.
Alternatively, the pusher member 130 may be fixed relative to the positioning member 140, for example, mechanically bonded, chemically bonded, interference fit, and the like. For example, the distal end 134 of the pusher member 130 may be fixed a predetermined distance proximal to the positioning element 146, e.g., to provide the sealant 2 immediately adjacent the positioning element 146, as shown in
Optionally, the system 10 may include a locking member (not shown) for coupling the introducer sheath 20 to the cartridge 120 during use such that subsequent movement of the cartridge 120, e.g., proximally during retraction, causes the introducer sheath 20 to be pulled or otherwise moved along with the cartridge 120. This coupling may prevent accidental proximal movement of the cartridge 120 independent of the introducer sheath 20, which may otherwise result in deploying the sealant 2 from the cartridge 120 within the introducer sheath 20, rather than within a puncture itself. Exemplary embodiments of locking elements that may be used are disclosed in co-pending U.S. patent application Ser. No. 11/864,835, incorporated by reference above.
Turning to
The tension indicator assembly 400 may include a two-piece housing, including a proximal housing portion 148a and a distal housing portion 148b, surrounding the cylinder 416. Optionally, the proximal housing portion 148a may be shaped to provide a handle to facilitate manipulating the positioning member 140 and/or to facilitate pulling the proximal housing portion 148a away from the distal housing portion 148b during use. The distal housing portion 148b may be substantially fixed relative to the cylinder 416, and the proximal housing portion 148a may be movable proximally away from or otherwise relative to the distal housing portion 148b (and consequently the cylinder 416 and other portions of the positioning member 140), yet biased to return towards the distal housing portion 148b.
As shown in
The cylindrical sleeve 410 may be sized such that the proximal housing portion 148a may be slidably disposed around the cylindrical sleeve 410, as described further below. Optionally, the cylindrical sleeve 410 and/or proximal housing portion 148a may include one or more features for limiting movement of the proximal housing portion 148a relative to the cylinder 410 (and consequently relative to the distal housing portion 148b). For example, as best seen in
A spring or other biasing element 402 (see
For example, when the desired amount of tension is applied between the proximal and distal ends 142, 144 of the positioning member 140, the spring 402 may compress, allowing the proximal and distal housing portions 148a, 148b to separate from one another, as shown in
In the embodiment shown, the spring 402 is a compression spring that is initially in a first position corresponding to a relatively relaxed state (shown in
As shown in
The distal housing portion 148b may be attached to the cylinder 416 in any manner. In the embodiment shown in
With continued reference to
The components of the proximal housing portion 148a are then attached together around the cylinder 416 and cylindrical sleeve 410, e.g., such that the cylindrical sleeve 410 is encircled by the shoulder 408 of the proximal housing portion 148a and the hollow cylinder 410 extends into the proximal housing portion 148a when the spring 402 is in the relatively relaxed state. As described above, the proximal housing portion 148a, including the shoulder 408 and any other components, may be integrally molded or otherwise formed, e.g., as halves that may be attached together and/or slidably attached around the cylinder 416. Thus, the hollow cylinder 410 and the cylinder 416 coupled thereto are configured to slide in and out of the proximal housing portion 148a through an opening created by the shoulder 408 while the spring 402 remains within the proximal housing portion 148a between the shoulder 408 and the spring retaining ring 406.
Turning to
In an exemplary method, the puncture 90 may be created using known procedures, e.g., using a needle, guidewire, one or more dilators, and the like (not shown). Then, as depicted in
The distal end 144 of the positioning member 140 may be introduced into the puncture 90, e.g., through the lumen 26 of the introducer sheath 20, with the expandable positioning element 146 in a collapsed condition, as shown in
Still referring to
In an exemplary method, this may involve a two-step process (although it may be completed in a single, substantially continuous action). First, with the positioning element 146 expanded within the vessel 94, as shown in
The tension indicator apparatus 400 may facilitate confirming that excessive force is not applied by the positioning element 146 to the vessel 94, e.g., by identifying that an optimal amount of tension is being applied by the positioning member 140, e.g., during deployment of the sealant 2. For example, if the positioning member 140 is withdrawn with excessive force after the positioning element 146 contacts the wall of the vessel 94, the wall of the vessel 94 may tent, which may cause damage to the wall of the vessel 94, and/or may cause ineffective or inaccurate sealing of the vessel 94. Conversely, if too little tension is applied, the vessel 94 may not be properly sealed from the puncture 90 and/or the sealant 2 may be deployed improperly, e.g., into the vessel 94. It may be desirable to provide additional indicators to the user in addition to using the first and second tactile feedback during withdrawal of the positioning member 140 because detection of the feedback depends on the tactile sensitivity of the user, which may be inaccurate.
Thus, the tension indicator assembly 400 may provide more accurate tension control, which may be calibrated by setting the spring constant of the spring 402 (not shown, see, e.g.,
Thus, as shown in
Turning to
In one embodiment, the cartridge 120 (and sealant 2) may be advanced through the introducer sheath 20 until a hub 123 of the cartridge 120 abuts a hub 23 on the introducer sheath 20. In another embodiment, the cartridge 120 may be advanced until a locking element (not shown) engages, thereby coupling the cartridge 120 to the introducer sheath 20.
Once the sealant 2 is in the desired position within the puncture 90 (shown in
When the sealant 2 is exposed within the puncture 90, the sealant 2 may be exposed to blood and/or other body fluids within the puncture 90. This exposure may cause the sealant 2 to absorb fluid and/or otherwise expand within the puncture 90, e.g., to provide hemostasis. If desired, once the sealant 2 is exposed within the puncture 90, the pusher member 130 may be advanced to compress or tamp the sealant 2, e.g., against the positioning element 146, as depicted by arrow 166 in
Once the sealant 2 has been exposed for sufficient time and/or tamped by the pusher member 130, the positioning element 146 may be collapsed, and the positioning member 140 withdrawn from the vessel 94 and puncture 90, e.g., by pulling the collapsed positioning element 146 through the sealant 2 and pusher member 130. The pusher member 130 may be maintained substantially stationary during withdrawal of the positioning member 140, e.g., to prevent migration and/or dislodgment of the sealant 2 within the puncture 90. Once the positioning member 140 is completely removed, the pusher member 130 may be removed from the puncture 90, leaving the sealant 2 within the puncture 90, as shown in
Optionally, after removing the positioning member 140, liquid hydrogel or other sealing compound, or other material may be delivered into the puncture 90, e.g., above and/or around the sealant 2, to assist in achieving hemostasis. For example, such material may be delivered via the lumen 136 of the pusher member 130 and/or by introducing another delivery device (not shown) into the puncture 90, e.g., after removing the pusher member 130. In another alternative, the cartridge 120 and sealant 2 may be eliminated, and the positioning member 140 may be used to substantially seal the puncture 90 from the vessel 94 temporarily. In this alternative, other sealants may then be delivered into the puncture 90, if desired, whereupon the positioning member 140 may be removed, as described above.
While the invention is susceptible to various modifications, and alternative forms, specific examples thereof have been shown in the drawings and are herein described in detail. It should be understood, however, that the invention is not to be limited to the particular forms or methods disclosed, but to the contrary, the invention is to cover all modifications, equivalents and alternatives falling within the scope of the appended claims.
This application is a divisional of U.S. patent application Ser. No. 14/191,237, filed on Feb. 26, 2014, titled “APPARATUS AND METHODS FOR SEALING A VASCULAR PUNCTURE”, which is a continuation-in-part of U.S. patent application Ser. No. 13/252,061, filed on Oct. 3, 2011, titled “APPARATUS AND METHODS FOR SEALING A VASCULAR PUNCTURE”, which is a continuation-in-part of U.S. patent application Ser. No. 12/098,380, filed on Apr. 4, 2008, titled “APPARATUS AND METHODS FOR SEALING A VASCULAR PUNCTURE”, all of which are incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
2115492 | Kober | Apr 1938 | A |
2365039 | Andresen | Dec 1944 | A |
3765419 | Usher | Oct 1973 | A |
4002173 | Manning et al. | Jan 1977 | A |
4260077 | Schroeder | Apr 1981 | A |
4327709 | Hanson et al. | May 1982 | A |
4362150 | Lombardi et al. | Dec 1982 | A |
4472542 | Nambu | Sep 1984 | A |
4540404 | Wolvek | Sep 1985 | A |
4655211 | Sakamoto et al. | Apr 1987 | A |
4664857 | Nambu | May 1987 | A |
4734097 | Tanabe et al. | Mar 1988 | A |
4738658 | Magro et al. | Apr 1988 | A |
4801434 | Kido et al. | Jan 1989 | A |
4838280 | Haaga | Jun 1989 | A |
4838864 | Peterson | Jun 1989 | A |
4852568 | Kensey | Aug 1989 | A |
4890612 | Kensey | Jan 1990 | A |
5053046 | Janese | Oct 1991 | A |
5061274 | Kensey | Oct 1991 | A |
5087246 | Smith | Feb 1992 | A |
5104375 | Wolf et al. | Apr 1992 | A |
5104389 | Deem et al. | Apr 1992 | A |
5108421 | Fowler | Apr 1992 | A |
5192300 | Fowler | Mar 1993 | A |
5192302 | Kensey et al. | Mar 1993 | A |
5221259 | Weldon et al. | Jun 1993 | A |
5222974 | Kensey et al. | Jun 1993 | A |
5258042 | Mehta | Nov 1993 | A |
5259835 | Clark et al. | Nov 1993 | A |
5275616 | Fowler | Jan 1994 | A |
5282827 | Kensey et al. | Feb 1994 | A |
5290310 | Makower et al. | Mar 1994 | A |
5292332 | Lee | Mar 1994 | A |
5306254 | Nash et al. | Apr 1994 | A |
5320639 | Rudnick | Jun 1994 | A |
5324306 | Makower et al. | Jun 1994 | A |
5334216 | Vidal et al. | Aug 1994 | A |
5370660 | Weinstein et al. | Dec 1994 | A |
5383896 | Gershony et al. | Jan 1995 | A |
RE34866 | Kensey et al. | Feb 1995 | E |
5391183 | Janzen et al. | Feb 1995 | A |
5409703 | McAnalley et al. | Apr 1995 | A |
5413571 | Katsaros et al. | May 1995 | A |
5419765 | Weldon et al. | May 1995 | A |
5431639 | Shaw | Jul 1995 | A |
5437292 | Kipshidze et al. | Aug 1995 | A |
5437631 | Janzen | Aug 1995 | A |
5441517 | Kensey et al. | Aug 1995 | A |
5443481 | Lee | Aug 1995 | A |
5464396 | Barta et al. | Nov 1995 | A |
5486195 | Myers et al. | Jan 1996 | A |
5489278 | Abrahamson | Feb 1996 | A |
5514158 | Kanesaka | May 1996 | A |
5529577 | Hammerslag | Jun 1996 | A |
5550187 | Woonza et al. | Aug 1996 | A |
5571181 | Li | Nov 1996 | A |
5580923 | Yeung et al. | Dec 1996 | A |
5584815 | Pawelka et al. | Dec 1996 | A |
5591204 | Janzen et al. | Jan 1997 | A |
5591205 | Fowler | Jan 1997 | A |
5601602 | Fowler | Feb 1997 | A |
5626601 | Gershony et al. | May 1997 | A |
5637086 | Ferguson et al. | Jun 1997 | A |
5643464 | Rhee et al. | Jul 1997 | A |
5649959 | Hannam et al. | Jul 1997 | A |
5660849 | Polson et al. | Aug 1997 | A |
5681279 | Roper et al. | Oct 1997 | A |
5700477 | Rosenthal et al. | Dec 1997 | A |
5707393 | Kensey et al. | Jan 1998 | A |
5716375 | Fowler | Feb 1998 | A |
5718916 | Scherr | Feb 1998 | A |
5725498 | Janzen et al. | Mar 1998 | A |
5725551 | Myers et al. | Mar 1998 | A |
5728122 | Leschinsky et al. | Mar 1998 | A |
5728132 | Tassel et al. | Mar 1998 | A |
5731368 | Stanley et al. | Mar 1998 | A |
5741223 | Janzen et al. | Apr 1998 | A |
5744153 | Yewey et al. | Apr 1998 | A |
5752974 | Rhee et al. | May 1998 | A |
5759193 | Burbank et al. | Jun 1998 | A |
5780044 | Yewey et al. | Jul 1998 | A |
5782860 | Epstein et al. | Jul 1998 | A |
5785679 | Abolfathi et al. | Jul 1998 | A |
5795331 | Cragg et al. | Aug 1998 | A |
5814016 | Valley et al. | Sep 1998 | A |
5830130 | Janzen et al. | Nov 1998 | A |
5836970 | Pandit | Nov 1998 | A |
5843124 | Hammerslag | Dec 1998 | A |
5868778 | Gershony et al. | Feb 1999 | A |
5916236 | Moer et al. | Jun 1999 | A |
5922009 | Epstein et al. | Jul 1999 | A |
5928266 | Kontos | Jul 1999 | A |
5941847 | Huber et al. | Aug 1999 | A |
5948429 | Bell et al. | Sep 1999 | A |
5948829 | Wallajapet et al. | Sep 1999 | A |
5951583 | Jensen et al. | Sep 1999 | A |
5951589 | Epstein | Sep 1999 | A |
5957952 | Gershony et al. | Sep 1999 | A |
5972375 | Truter et al. | Oct 1999 | A |
5973014 | Funk et al. | Oct 1999 | A |
6007563 | Nash et al. | Dec 1999 | A |
6017359 | Gershony et al. | Jan 2000 | A |
6022361 | Epstein et al. | Feb 2000 | A |
6027471 | Fallon et al. | Feb 2000 | A |
6045570 | Epstein et al. | Apr 2000 | A |
6048358 | Barak | Apr 2000 | A |
6051248 | Sawhney et al. | Apr 2000 | A |
6056768 | Cates et al. | May 2000 | A |
6056769 | Epstein et al. | May 2000 | A |
6063061 | Wallace et al. | May 2000 | A |
6063085 | Tay et al. | May 2000 | A |
6083522 | Chu et al. | Jul 2000 | A |
6086607 | Cragg et al. | Jul 2000 | A |
6090130 | Nash et al. | Jul 2000 | A |
6113611 | Allen et al. | Sep 2000 | A |
6117145 | Wood et al. | Sep 2000 | A |
6152943 | Sawhney | Nov 2000 | A |
6162192 | Cragg et al. | Dec 2000 | A |
6162240 | Cates et al. | Dec 2000 | A |
6162241 | Coury et al. | Dec 2000 | A |
6165201 | Sawhney et al. | Dec 2000 | A |
6179862 | Sawhney | Jan 2001 | B1 |
6179863 | Kensey et al. | Jan 2001 | B1 |
6223936 | Jeanbourquin | May 2001 | B1 |
6238412 | Dubrul et al. | May 2001 | B1 |
6271278 | Park et al. | Aug 2001 | B1 |
6287323 | Hammerslag | Sep 2001 | B1 |
6296658 | Gershony et al. | Oct 2001 | B1 |
6299597 | Buscemi et al. | Oct 2001 | B1 |
6302898 | Edwards et al. | Oct 2001 | B1 |
6315753 | Cragg et al. | Nov 2001 | B1 |
6325789 | Janzen et al. | Dec 2001 | B1 |
6350274 | Li | Feb 2002 | B1 |
6368300 | Fallon et al. | Apr 2002 | B1 |
6371975 | Cruise et al. | Apr 2002 | B2 |
6379373 | Sawhney et al. | Apr 2002 | B1 |
6458147 | Cruise et al. | Oct 2002 | B1 |
6464712 | Epstein et al. | Oct 2002 | B1 |
6475177 | Suzuki | Nov 2002 | B1 |
6514534 | Sawhney | Feb 2003 | B1 |
6540735 | Ashby et al. | Apr 2003 | B1 |
6562059 | Edwards et al. | May 2003 | B2 |
6566406 | Pathak et al. | May 2003 | B1 |
6569185 | Ungs | May 2003 | B2 |
6605294 | Sawhney | Aug 2003 | B2 |
6608117 | Gvozdic | Aug 2003 | B1 |
6610026 | Cragg et al. | Aug 2003 | B2 |
6613070 | Redmond et al. | Sep 2003 | B2 |
6626861 | Hart et al. | Sep 2003 | B1 |
6626918 | Ginn et al. | Sep 2003 | B1 |
6635068 | Dubrul et al. | Oct 2003 | B1 |
6689148 | Sawhney et al. | Feb 2004 | B2 |
6699261 | Cates et al. | Mar 2004 | B1 |
6703047 | Sawhney et al. | Mar 2004 | B2 |
6774151 | Malmgren et al. | Aug 2004 | B2 |
6818008 | Cates et al. | Nov 2004 | B1 |
6818018 | Sawhney | Nov 2004 | B1 |
6860895 | Akerfeldt et al. | Mar 2005 | B1 |
6863924 | Ranganathan et al. | Mar 2005 | B2 |
6887974 | Pathak | May 2005 | B2 |
6890342 | Zhu et al. | May 2005 | B2 |
6890343 | Ginn et al. | May 2005 | B2 |
6960617 | Omidian et al. | Nov 2005 | B2 |
6994686 | Cruise et al. | Feb 2006 | B2 |
7009034 | Pathak et al. | Mar 2006 | B2 |
7118578 | West et al. | Oct 2006 | B2 |
7316704 | Bagaoisan et al. | Jan 2008 | B2 |
7331979 | Khosravi et al. | Feb 2008 | B2 |
7335220 | Khosravi et al. | Feb 2008 | B2 |
7553319 | Bagaoisan et al. | Jun 2009 | B2 |
7572274 | Yassinzadeh | Aug 2009 | B2 |
7611479 | Cragg et al. | Nov 2009 | B2 |
7618438 | White et al. | Nov 2009 | B2 |
7621936 | Cragg et al. | Nov 2009 | B2 |
7662161 | Briganti et al. | Feb 2010 | B2 |
7790192 | Sawhney et al. | Sep 2010 | B2 |
7806856 | Bagaoisan et al. | Oct 2010 | B2 |
7850710 | Huss | Dec 2010 | B2 |
7955353 | Ashby et al. | Jun 2011 | B1 |
3002742 | Pai et al. | Aug 2011 | A1 |
7988706 | Forsberg et al. | Aug 2011 | B2 |
7993367 | Bagaoisan et al. | Aug 2011 | B2 |
8029533 | Bagaoisan et al. | Oct 2011 | B2 |
8262693 | Pai et al. | Sep 2012 | B2 |
8568445 | Pipenhagen et al. | Oct 2013 | B2 |
8795709 | Sawhney et al. | Aug 2014 | B2 |
8870917 | Walters | Oct 2014 | B2 |
9289195 | Bagaoisan et al. | Mar 2016 | B2 |
9364206 | Bagaoisan et al. | Jun 2016 | B2 |
9668719 | Tegels et al. | Jun 2017 | B2 |
9895144 | Tegels et al. | Feb 2018 | B2 |
20010031948 | Cruise et al. | Oct 2001 | A1 |
20010046518 | Sawhney | Nov 2001 | A1 |
20010047187 | Milo et al. | Nov 2001 | A1 |
20010051813 | Hnojewyj | Dec 2001 | A1 |
20020015724 | Yang et al. | Feb 2002 | A1 |
20020062104 | Ashby et al. | May 2002 | A1 |
20020072767 | Zhu | Jun 2002 | A1 |
20020106409 | Sawhney et al. | Aug 2002 | A1 |
20020111392 | Cruise | Aug 2002 | A1 |
20020111651 | Ungs | Aug 2002 | A1 |
20020120228 | Maa et al. | Aug 2002 | A1 |
20020188319 | Morris et al. | Dec 2002 | A1 |
20020193808 | Belef et al. | Dec 2002 | A1 |
20030008831 | Yang et al. | Jan 2003 | A1 |
20030012734 | Pathak et al. | Jan 2003 | A1 |
20030051735 | Pavcnik et al. | Mar 2003 | A1 |
20030061735 | Polifroni | Apr 2003 | A1 |
20030088269 | Ashby | May 2003 | A1 |
20030088271 | Cragg et al. | May 2003 | A1 |
20030109899 | Fisher et al. | Jun 2003 | A1 |
20030135234 | Fisher et al. | Jul 2003 | A1 |
20030135235 | Fisher et al. | Jul 2003 | A1 |
20030135236 | Fisher et al. | Jul 2003 | A1 |
20030135237 | Cragg et al. | Jul 2003 | A1 |
20030139770 | Fisher et al. | Jul 2003 | A1 |
20030139771 | Fisher et al. | Jul 2003 | A1 |
20030139772 | Fisher et al. | Jul 2003 | A1 |
20030139773 | Fisher et al. | Jul 2003 | A1 |
20030233120 | Akerfeldt et al. | Dec 2003 | A1 |
20040010287 | Bonutti | Jan 2004 | A1 |
20040122350 | Zhong et al. | Jun 2004 | A1 |
20040143290 | Brightbill | Jul 2004 | A1 |
20040147016 | Rowley et al. | Jul 2004 | A1 |
20040176798 | Epstein et al. | Sep 2004 | A1 |
20040236262 | McIntosh et al. | Nov 2004 | A1 |
20040249342 | Khosravi et al. | Dec 2004 | A1 |
20040267193 | Bagaoisan et al. | Dec 2004 | A1 |
20040267307 | Bagaoisan et al. | Dec 2004 | A1 |
20040267308 | Bagaoisan et al. | Dec 2004 | A1 |
20050085773 | Forsberg et al. | Apr 2005 | A1 |
20050085851 | Fiehler et al. | Apr 2005 | A1 |
20050085852 | Ditter | Apr 2005 | A1 |
20050085855 | Forsberg et al. | Apr 2005 | A1 |
20050267522 | Yassinzadeh | Dec 2005 | A1 |
20050277980 | Yassinzadeh | Dec 2005 | A1 |
20060034930 | Sawhney et al. | Feb 2006 | A1 |
20060099238 | Khosravi et al. | May 2006 | A1 |
20060100664 | Pai et al. | May 2006 | A1 |
20060161188 | Kennedy et al. | Jul 2006 | A1 |
20060229673 | Forsberg et al. | Oct 2006 | A1 |
20060229674 | Forsberg et al. | Oct 2006 | A1 |
20060241579 | Kawaura et al. | Oct 2006 | A1 |
20060253037 | Ginn et al. | Nov 2006 | A1 |
20060253072 | Pai et al. | Nov 2006 | A1 |
20060265007 | White et al. | Nov 2006 | A1 |
20070060950 | Khosravi et al. | Mar 2007 | A1 |
20070088362 | Bonutti et al. | Apr 2007 | A1 |
20070231366 | Sawhney et al. | Oct 2007 | A1 |
20070255314 | Forsberg et al. | Nov 2007 | A1 |
20080009794 | Bagaoisan et al. | Jan 2008 | A1 |
20080082122 | Khosravi et al. | Apr 2008 | A1 |
20080221615 | Ginn et al. | Sep 2008 | A1 |
20080243182 | Bates et al. | Oct 2008 | A1 |
20080269800 | Spurchise et al. | Oct 2008 | A1 |
20090088793 | Bagaoisan et al. | Apr 2009 | A1 |
20090318955 | Dave et al. | Dec 2009 | A1 |
20100211000 | Killion et al. | Aug 2010 | A1 |
20130190813 | Tegels et al. | Jul 2013 | A1 |
20140135826 | Tegels et al. | May 2014 | A1 |
20140180334 | Bagaoisan et al. | Jun 2014 | A1 |
20160324511 | Bagaoisan et al. | Nov 2016 | A1 |
Number | Date | Country |
---|---|---|
0476178 | Mar 1992 | EP |
0482350 | Apr 1992 | EP |
0716833 | Jun 1996 | EP |
2811912 | Jun 2017 | EP |
9222252 | Dec 1992 | WO |
9413210 | Jun 1994 | WO |
9428798 | Dec 1994 | WO |
9922646 | May 1999 | WO |
0014155 | Mar 2000 | WO |
0019912 | Apr 2000 | WO |
03004749 | Jan 2003 | WO |
03009764 | Feb 2003 | WO |
03087254 | Oct 2003 | WO |
03094749 | Nov 2003 | WO |
2006115904 | Nov 2006 | WO |
2008036634 | Mar 2008 | WO |
Entry |
---|
Office Actions and Responses for related U.S. Appl. No. 11/864,835, filed Sep. 28, 2007; First named Inventor: Celso J. Bagaoisan; dated Mar. 1, 2010-Feb. 4, 2011; 46 pages. |
Office Actions and Responses for related U.S. Appl. No. 12/098,380, correspondence dated Sep. 23, 2010-Jun. 14, 2011; 48 pages. |
PCT International Search Report and Written Opinion for PCT/US2008/077406, Applicant: AccessClosure, Inc., Forms PCT/ISA/220, PCT/ISA/210, and PCT/ISA/237; dated Dec. 22, 2008, 11 pages. |
St. Jude Medical, Angio-Seal Evolution Vascular Closure Device, Instructions for Use, 2008, 12 pages. |
Number | Date | Country | |
---|---|---|---|
20200375582 A1 | Dec 2020 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14191237 | Feb 2014 | US |
Child | 16827702 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13252061 | Oct 2011 | US |
Child | 14191237 | US | |
Parent | 12098380 | Apr 2008 | US |
Child | 13252061 | US |